Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Diagnosis, stratification and monitoring of disease progression in amyotrophic lateral sclerosis currently rely on clinical history and examination. The phenotypic heterogeneity of amyotrophic lateral sclerosis, including extramotor cognitive impairments is now well recognized. Candidate biomarkers have shown variable sensitivity and specificity, and studies have been mainly undertaken only cross-sectionally. Sixty patients with sporadic amyotrophic lateral sclerosis (without a family history of amyotrophic lateral sclerosis or dementia) underwent baseline multimodal magnetic resonance imaging at 3 T. Grey matter pathology was identified through analysis of T1-weighted images using voxel-based morphometry. White matter pathology was assessed using tract-based spatial statistics analysis of indices derived from diffusion tensor imaging. Cross-sectional analyses included group comparison with a group of healthy controls (n = 36) and correlations with clinical features, including regional disability, clinical upper motor neuron signs and cognitive impairment. Patients were offered 6-monthly follow-up MRI, and the last available scan was used for a separate longitudinal analysis (n = 27). In cross-sectional study, the core signature of white matter pathology was confirmed within the corticospinal tract and callosal body, and linked strongly to clinical upper motor neuron burden, but also to limb disability subscore and progression rate. Localized grey matter abnormalities were detected in a topographically appropriate region of the left motor cortex in relation to bulbar disability, and in Broca's area and its homologue in relation to verbal fluency. Longitudinal analysis revealed progressive and widespread changes in the grey matter, notably including the basal ganglia. In contrast there was limited white matter pathology progression, in keeping with a previously unrecognized limited change in individual clinical upper motor neuron scores, despite advancing disability. Although a consistent core white matter pathology was found cross-sectionally, grey matter pathology was dominant longitudinally, and included progression in clinically silent areas such as the basal ganglia, believed to reflect their wider cortical connectivity. Such changes were significant across a range of apparently sporadic patients rather than being a genotype-specific effect. It is also suggested that the upper motor neuron lesion in amyotrophic lateral sclerosis may be relatively constant during the established symptomatic period. These findings have implications for the development of effective diagnostic versus therapeutic monitoring magnetic resonance imaging biomarkers. Amyotrophic lateral sclerosis may be characterized initially by a predominantly white matter tract pathological signature, evolving as a widespread cortical network degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630 · cited 6×
“As part of the preprocessing pipeline for the FSL-VBM longitudinal analysis, for each of the 27 patients who had both structural images and DTI images for at least two time points (T0 and TMAX), images were bias field-corrected, brain-extracted, and halfway linear registration matrices between T0 and TMAX scans were c…”
MethodInfluentialJenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Fast robust automated brain extraction
Smith, S. M. (2002) · Human Brain Mapping · doi:10.1002/hbm.10062 · Cited by 10,496 · cited 2×
“Ethical approval for all procedures was obtained in advance (South Central Oxford Ethics Committee: 08/H0605/85), with written informed consent obtained from all participants.”
MethodZhang, Y., Brady, M., & Smith, S. (2001) · IEEE Transactions on Medical Imaging · doi:10.1109/42.906424 · Cited by 6,982 · cited 2×
“Next, tissue-type segmentation was carried out using FAST4 (Zhang et al., 2001).”
MethodA global optimisation method for robust affine registration of brain images
Jenkinson, M., & Smith, S. (2001) · Medical Image Analysis · doi:10.1016/s1361-8415(01)00036-6 · Cited by 6,872 · cited 3×
“The resulting grey matter partial volume images were then aligned into MNI space using the affine registration tool FLIRT, followed by non-linear registration using FNIRT.”
MethodTract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., Watkins, K. E., Ciccarelli, O., Cader, M. Z., Matthews, P. M., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.024 · Cited by 6,478 · cited 1×
“Next, the mean fractional anisotropy image was created and thinned to create a mean fractional anisotropy skeleton (Smith et al., 2006), which represents the centres of all tracts common to the group.”
MethodEl Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · cited 2×
“Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis”
BackgroundSMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250 · cited 2×
“Subsequently, using FNIRT, the bias field corrected T0 and TMAX images were non-linearly registered to their average image in halfway space that was obtained after linear registration.”
MethodInfluentialA Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307 · cited 1×
“Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis”
BackgroundKiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Self-citationNon-invasive mapping of connections between human thalamus and cortex using diffusion imaging
Behrens, T. E. J., Johansen-Berg, H., Woolrich, M. W., Smith, S. M., Wheeler-Kingshott, C. A. M., Boulby, P. A., Barker, G. J., Sillery, E. L., Sheehan, K., Ciccarelli, O., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1075 · Cited by 2,330 · cited 1×
“Fractional anisotropy, mean diffusivity, axial diffusivity (eigenvector L1) and L2 and L3 maps were created using DTIFIT by applying a diffusion tensor model to each voxel (Behrens et al., 2003).”
MethodMioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016 · cited 1×
“Cognitive assessment was undertaken using the revised Addenbrooke’s Cognitive Examination Score (ACE-R, maximum score 100, with subscores for verbal fluency for ‘p words in 1 minute’, ‘animals in 1 minute’, and a memory task, each scored 0–7) (Mioshi et al., 2006).”
MethodThe epidemiology of ALS: a conspiracy of genes, environment and time
Al-Chalabi, A., & Hardiman, O. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.203 · Cited by 894 · cited 2×
“The conclusion is that there may be several upstream points of access to a neurodegenerative process (Al-Chalabi and Hardiman, 2013; Turner et al., 2013), one that then consist- ently affects upper, lower and extramotor neurons, but to varying extents, typically with the common endpoint of…”
BackgroundAnatomically related grey and white matter abnormalities in adolescent-onset schizophrenia
Douaud, G., Smith, S., Jenkinson, M., Behrens, T., Johansen-Berg, H., Vickers, J., James, S., Voets, N., Watkins, K., Matthews, P. M., et al. (2007) · Brain · doi:10.1093/brain/awm184 · Cited by 771 · cited 1×
“T1-weighted MP-RAGE data was analysed with FSL-VBM, a voxelbased morphometry (VBM) style analysis (Good et al., 2001; Smith et al., 2004; Douaud et al., 2007).”
MethodSelf-citationTurner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737 · cited 2×
“An upper motor neuron clinical burden score out of 15 comprised the number of pathologically brisk reflexes [extensor plantar responses (2), brisk facial and jaw jerks (3), biceps (2), supinator (2), triceps (2), finger (2), knee (2), and ankle reflexes] (Turner et al., 2004).”
BackgroundSelf-citationALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration
Ravits, J. M., & La Spada, A. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bbbd · Cited by 604
Controversies and priorities in amyotrophic lateral sclerosis
Turner, M. R., Hardiman, O., Benatar, M., Brooks, B. R., Chio, A., de Carvalho, M., Ince, P. G., Lin, C., Miller, R. G., Mitsumoto, H., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70036-x · Cited by 541 · cited 2×
“The conclusion is that there may be several upstream points of access to a neurodegenerative process (Al-Chalabi and Hardiman, 2013; Turner et al., 2013), one that then consist- ently affects upper, lower and extramotor neurons, but to varying extents, typically with the common endpoint of…”
BackgroundSelf-citationAmyotrophic lateral sclerosis—a model of corticofugal axonal spread
Braak, H., Brettschneider, J., Ludolph, A. C., Lee, V. M., Trojanowski, J. Q., & Tredici, K. D. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.221 · Cited by 527 · cited 1×
“Clinicopathological correlations in ALS suggest a pathological process involving, at least in part, a top–down cortical degener- ation topographically related to regional anterior horn involvement (Eisen et al., 1992; Ravits and La Spada, 2009; Braak et al., 2013).”
BackgroundByrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., Heverin, M., Jordan, N., Kenna, K., Lynch, C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70014-5 · Cited by 484 · cited 1×
“Marked fronto- temporal grey matter changes have been observed in those with frank frontotemporal dementia (Chang et al., 2005), and in those ALS cases linked to C9orf72 hexanucleotide repeat expansions, known to have consistent cognitive impairments (Byrne et al., 2012).”
BackgroundThe central nervous system in motor neurone disease
Brownell, B., Oppenheimer, D. R., & Hughes, J. T. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.3.338 · Cited by 483 · cited 2×
“Upper motor neuron involvement is demonstrable pathologically even in ALS cases with only lower motor neuron involvement clinically (Brownell et al., 1970; Ince et al., 2003), and its detection alongside the more typical lower motor neuron involvement in ALS is a cornerstone of diagnostic certainty.”
BackgroundFunctional magnetic resonance imaging of human brain activity in a verbal fluency task
Schlosser, R., Hutchinson, M., Joseffer, S., Rusinek, H., Saarimaki, A., Stevenson, J., Dewey, S. L., & Brodie, J. D. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.492 · Cited by 439 · cited 2×
“Activation studies have linked verbal fluency to Broca’s area and the dorsolateral prefrontal cortices in healthy individuals (Schlosser et al., 1998), confirmed using activation PET in patients with ALS (Abrahams et al., 1996), and with evidence of specific regional microglial activation (Turner…”
BackgroundVerbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)
Abrahams, S., Leigh, P. N., Harvey, A., Vythelingum, G. N., Grisé, D., & Goldstein, L. H. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00146-3 · Cited by 411
The genetics and neuropathology of amyotrophic lateral sclerosis
Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S., & van den Berg, L. H. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1022-4 · Cited by 398 · cited 2×
“Although genetic factors may influence the dominance of pathological involvement to some extent (Al-Chalabi et al., 2012), 95% of patients report no family history of ALS or frontotemporal dementia, and cur- rently have no obvious single genetic mutation that accounts for their disease despite…”
BackgroundCorticospinal tract degeneration in the progressive muscular atrophy variant of ALS
Ince, P. G., Evans, J., Knopp, M., Forster, G., Hamdalla, H. H. M., Wharton, S. B., & Shaw, P. J. (2003) · Neurology · doi:10.1212/01.wnl.0000058901.75728.4e · Cited by 304 · cited 2×
“Upper motor neuron involvement is demonstrable pathologically even in ALS cases with only lower motor neuron involvement clinically (Brownell et al., 1970; Ince et al., 2003), and its detection alongside the more typical lower motor neuron involvement in ALS is a cornerstone of diagnostic certainty.”
BackgroundExecutive dysfunction is a negative prognostic indicator in patients with ALS without dementia
Elamin, M., Phukan, J., Bede, P., Jordan, N., Byrne, S., Pender, N., & Hardiman, O. (2011) · Neurology · doi:10.1212/wnl.0b013e318214359f · Cited by 301 · cited 2×
“Half of patients with ALS demonstrate evidence of frontotemporal cognitive impairment, independently linked to faster progression (Elamin et al., 2011).”
BackgroundCorpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis
Filippini, N., Douaud, G., Mackay, C. E., Knight, S., Talbot, K., & Turner, M. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fb84d1 · Cited by 280 · cited 6×
“The consistent DTI changes identified previously within the corticospinal tracts and corpus callosum (Kassubek et al., 2005; Filippini et al., 2010) have been replicated in many studies, and also related to clinical upper motor neuron signs (studies comprehensively reviewed in Turner et al.”
BackgroundMethodResultInfluentialSelf-citationFrontal lobe dysfunction in amyotrophic lateral sclerosis: A PET study
Abrahams, S., Goldstein, L. H., Kew, J. J. M., Brooks, D. J., Lloyd, C. M., Frith, C. D., & Leigh, P. N. (1996) · Brain · doi:10.1093/brain/119.6.2105 · Cited by 276 · cited 1×
“…have linked verbal fluency to Broca’s area and the dorsolateral prefrontal cortices in healthy individuals (Schlosser et al., 1998), confirmed using activation PET in patients with ALS (Abrahams et al., 1996), and with evidence of specific regional microglial activation (Turner et al., 2004).”
BackgroundCognitive changes predict functional decline in ALS: A population-based longitudinal study
Elamin, M., Bede, P., Byrne, S., Jordan, N., Gallagher, L., Wynne, B., O’Brien, C., Phukan, J., Lynch, C., Pender, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f18ac · Cited by 272 · cited 2×
“…theme, it has been noted that cognitive involvement does not generally progress significantly in those without major impairments at baseline (Elamin et al., 2013), supporting a broader concept of variably ‘compartmentalized’ symptoms in ALS (between upper motor neuron, lower motor neuron…”
BackgroundA voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD
Chang, J. L., Lomen-Hoerth, C., Murphy, J., Henry, R. G., Kramer, J. H., Miller, B. L., & Gorno-Tempini, M. L. (2005) · Neurology · doi:10.1212/01.wnl.0000167602.38643.29 · Cited by 268 · cited 4×
“More widespread grey matter changes have been most prominent in studies of the 10–15% of patients with ALS with frank frontotemporal dementia (Chang et al., 2005), or in ALS genotypes such as C9orf72, which are more consistently associated with marked frontotemporal de- mentia-spectrum cognitive…”
BackgroundInfluentialIntegration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis
Douaud, G., Filippini, N., Knight, S., Talbot, K., & Turner, M. R. (2011) · Brain · doi:10.1093/brain/awr279 · Cited by 247 · cited 3×
“A smaller proportion of these patients have appeared in previously published studies undertaken as the cohort was still being recruited (Filippini et al., 2010; Douaud et al., 2011; Menke et al., 2012; Kolind et al., 2013; Stagg et al., 2013).”
BackgroundResultSelf-citationAmyotrophic lateral sclerosis (ALS): A phylogenetic disease of the corticomotoneuron?
Eisen, A., Kim, S., & Pant, B. (1992) · Muscle & Nerve · doi:10.1002/mus.880150215 · Cited by 237 · cited 1×
“Clinicopathological correlations in ALS suggest a pathological process involving, at least in part, a top–down cortical degener- ation topographically related to regional anterior horn involvement (Eisen et al., 1992; Ravits and La Spada, 2009; Braak et al., 2013).”
BackgroundQuantitative diffusion tensor imaging in amyotrophic lateral sclerosis
Sage, C. A., Peeters, R. R., Görner, A., Robberecht, W., & Sunaert, S. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.025 · Cited by 207 · cited 2×
“…undertaken to date, signifi- cant white and grey matter changes over time have been observed in some (Agosta et al., 2009; Senda et al., 2011; van der Graaff et al., 2011; Keil et al., 2012; Verstraete et al., 2012), but not others (Blain et al., 2007; Mitsumoto et al., 2007; Sage et al., 2007).”
BackgroundNERVE FIBRE DEGENERATION IN THE BRAIN IN AMYOTROPHIC LATERAL SCLEROSIS
Smith, M. C. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.4.269 · Cited by 203 · cited 2×
“Post-mortem studies have identified widespread extramotor as well as motor white matter degener- ation (Smith, 1960).”
BackgroundQuantitative objective markers for upper and lower motor neuron dysfunction in ALS
Mitsumoto, H., Uluğ, A. M., Pullman, S. L., Gooch, C. L., Chan, S., Tang, M. X., Mao, X., Hays, A. P., Floyd, A. G., Battista, V., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000260065.57832.87 · Cited by 203 · cited 1×
“…undertaken to date, signifi- cant white and grey matter changes over time have been observed in some (Agosta et al., 2009; Senda et al., 2011; van der Graaff et al., 2011; Keil et al., 2012; Verstraete et al., 2012), but not others (Blain et al., 2007; Mitsumoto et al., 2007; Sage et al., 2007).”
BackgroundKassubek, J., Unrath, A., Huppertz, H., Lulé, D., Ethofer, T., Sperfeld, A., & Ludolph, A. C. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510038538 · Cited by 181 · cited 2×
“The consistent DTI changes identified previously within the corticospinal tracts and corpus callosum (Kassubek et al., 2005; Filippini et al., 2010) have been replicated in many studies, and also related to clinical upper motor neuron signs (studies comprehensively reviewed in Turner et al.”
ResultBasal ganglia involvement in amyotrophic lateral sclerosis
Bede, P., Elamin, M., Byrne, S., McLaughlin, R. L., Kenna, K., Vajda, A., Pender, N., Bradley, D. G., & Hardiman, O. (2013) · Neurology · doi:10.1212/01.wnl.0000437313.80913.2c · Cited by 176 · cited 14×
“The revised ALS Functional Rating Scale (ALSFRS-R) was used to assess disability (including analysis of bulbar, upper and lower limb subscores, with lower total score reflecting higher disability) (Cedarbaum et al., 1999).”
BackgroundInfluentialTowards a neuroimaging biomarker for amyotrophic lateral sclerosis
Turner, M. R., Grosskreutz, J., Kassubek, J., Abrahams, S., Agosta, F., Benatar, M., Filippi, M., Goldstein, L. H., van den Heuvel, M., Kalra, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70049-7 · Cited by 171 · cited 2×
“, 2011), and MRI offers significant potential in all regards (Turner et al., 2011).”
BackgroundSelf-citationMultiparametric MRI study of ALS stratified for the C9orf72 genotype
Bede, P., Bokde, A. L. W., Byrne, S., Elamin, M., McLaughlin, R. L., Kenna, K., Fagan, A. J., Pender, N., Bradley, D. G., & Hardiman, O. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c5eee · Cited by 168 · cited 15×
“The revised ALS Functional Rating Scale (ALSFRS-R) was used to assess disability (including analysis of bulbar, upper and lower limb subscores, with lower total score reflecting higher disability) (Cedarbaum et al., 1999).”
BackgroundInfluentialThivard, L., Pradat, P.-F., Lehericy, S., Lacomblez, L., Dormont, D., Chiras, J., Benali, H., & Meininger, V. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.101758 · Cited by 163 · cited 12×
“The revised ALS Functional Rating Scale (ALSFRS-R) was used to assess disability (including analysis of bulbar, upper and lower limb subscores, with lower total score reflecting higher disability) (Cedarbaum et al., 1999).”
BackgroundInfluentialBede, P., Bokde, A. L. W., Elamin, M., Byrne, S., McLaughlin, R. L., Jordan, N., Hampel, H. J., Gallagher, L. B., Lynch, C. M., Fagan, A. J., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302674 · Cited by 153 · cited 14×
“The revised ALS Functional Rating Scale (ALSFRS-R) was used to assess disability (including analysis of bulbar, upper and lower limb subscores, with lower total score reflecting higher disability) (Cedarbaum et al., 1999).”
BackgroundInfluentialStructural MRI reveals cortical thinning in amyotrophic lateral sclerosis
Verstraete, E., Veldink, J. H., Hendrikse, J., Schelhaas, H. J., van den Heuvel, M. P., & van den Berg, L. H. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300909 · Cited by 150 · cited 4×
“…undertaken to date, signifi- cant white and grey matter changes over time have been observed in some (Agosta et al., 2009; Senda et al., 2011; van der Graaff et al., 2011; Keil et al., 2012; Verstraete et al., 2012), but not others (Blain et al., 2007; Mitsumoto et al., 2007; Sage et al., 2007).”
BackgroundInfluentialUpper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study
van der Graaff, M. M., Sage, C. A., Caan, M. W. A., Akkerman, E. M., Lavini, C., Majoie, C. B., Nederveen, A. J., Zwinderman, A. H., Vos, F., Brugman, F., et al. (2011) · Brain · doi:10.1093/brain/awr016 · Cited by 149
Neuroimaging in Amyotrophic Lateral Sclerosis
Turner, M. R., Agosta, F., Bede, P., Govind, V., Lulé, D., & Verstraete, E. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.26 · Cited by 146 · cited 3×
“…The consistent DTI changes identified previously within the corticospinal tracts and corpus callosum (Kassubek et al., 2005; Filippini et al., 2010) have been replicated in many studies, and also related to clinical upper motor neuron signs (studies comprehensively reviewed in Turner et al., 2012).”
BackgroundResultSelf-citationWhy are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?: Figure 1
Swash, M. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302315 · Cited by 145 · cited 2×
“motor neuron signs may be difficult to detect clinically (Swash, 2012).”
BackgroundInvestigation of white matter pathology in ALS and PLS using tract‐based spatial statistics
Ciccarelli, O., Behrens, T. E., Johansen‐Berg, H., Talbot, K., Orrell, R. W., Howard, R. S., Nunes, R. G., Miller, D. H., Matthews, P. M., Thompson, A. J., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20527 · Cited by 140 · cited 1×
“…are mainly located in the interhemispheric motor fibres of the body (Chapman et al., 2013), and seem exaggerated in patients with primary lateral sclerosis which are considered part of the spectrum of ALS in the wider use of the diagnostic term (Ciccarelli et al., 2009; Agosta et al., 2013).”
BackgroundSelf-citationProlonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002
Turner, M. R. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.995 · Cited by 139 · cited 2×
“A very rare variant known as primary lateral sclerosis demonstrates only upper motor neuron involvement clinically, with characteristically long survival, and those with ‘pure’ lower motor neuron involvement are also typically slower in rate of progression (Turner et al., 2003).”
BackgroundSelf-citationPresymptomatic studies in ALS: Rationale, challenges, and approach
Benatar, M., & Wuu, J. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e9b1d · Cited by 122
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
Bowser, R. P., Turner, M. R., & Shefner, J. M. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.151 · Cited by 119 · cited 3×
“There are no fully validated biomarkers for diagnosis, stratification or therapeutic monitoring in ALS, although candidates are emerging from neuroimaging, body fluids and neurophysiology (Bowser et al., 2011).”
BackgroundSelf-citationMitchell, J. D., Callagher, P., Gardham, J., Mitchell, C., Dixon, M., Addison-Jones, R., Bennett, W., & O'Brien, M. R. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.495158 · Cited by 115 · cited 2×
“symptom onset to diagnosis in ALS (Mitchell et al., 2010).”
BackgroundSenda, J., Kato, S., Kaga, T., Ito, M., Atsuta, N., Nakamura, T., Watanabe, H., Tanaka, F., Naganawa, S., & Sobue, G. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.517850 · Cited by 108 · cited 2×
“In the small number of studies undertaken to date, significant white and grey matter changes over time have been observed in some (Agosta et al., 2009; Senda et al., 2011; van der Graaff et al., 2011; Keil et al., 2012; Verstraete et al., 2012), but not others (Blain et al.”
BackgroundSarro, L., Agosta, F., Canu, E., Riva, N., Prelle, A. C., Copetti, M., Riccitelli, G. C., Comı, G., & Filippi, M. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2658 · Cited by 107 · cited 2×
“…and executive dysfunction linked to the corpus callosum, corticospinal tract, cingulum, inferior longitudinal, inferior fronto-occipital, and uncinate fasciculi; verbal learning and memory test scores to the fornix; and visual-spatial abilities to the left uncinate fasciculus (Sarro et al., 2011).”
BackgroundMethodLongitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
Keil, C., Prell, T., Peschel, T., Hartung, V., Dengler, R., & Großkreutz, J. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-141 · Cited by 103 · cited 3×
“…undertaken to date, signifi- cant white and grey matter changes over time have been observed in some (Agosta et al., 2009; Senda et al., 2011; van der Graaff et al., 2011; Keil et al., 2012; Verstraete et al., 2012), but not others (Blain et al., 2007; Mitsumoto et al., 2007; Sage et al., 2007).”
BackgroundA longitudinal study of diffusion tensor MRI in ALS
Blain, C. R. V., Williams, V. C., Johnston, C. A., Stanton, B. R., Ganesalingam, J., Jarosz, J., Jones, D. K., Barker, G. J., Williams, S., Leigh, N. P., et al. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701548139 · Cited by 92 · cited 2×
“…undertaken to date, signifi- cant white and grey matter changes over time have been observed in some (Agosta et al., 2009; Senda et al., 2011; van der Graaff et al., 2011; Keil et al., 2012; Verstraete et al., 2012), but not others (Blain et al., 2007; Mitsumoto et al., 2007; Sage et al., 2007).”
BackgroundKwan, J. Y., Meoded, A., Danielian, L. E., Wu, T., & Floeter, M. K. (2012) · NeuroImage Clinical · doi:10.1016/j.nicl.2012.12.003 · Cited by 91 · cited 2×
“A study of a small number of patients with ALS scanned longitudinally specifically noted motor cortex grey matter atrophy over time, but no progression in the reduction in fractional anisotropy (a measure of fibre tract integrity) of corticospinal tract white matter (Kwan et al., 2012).”
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases
Filippi, M., Agosta, F., Abrahams, S., Fazekas, F., Grosskreutz, J., Kalra, S., Kassubek, J., Silani, V., Turner, M. R., & Masdeu, J. C. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02951.x · Cited by 87 · cited 4×
“Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis”
BackgroundMethodInfluentialSelf-citationChen, Z., & Ma, L. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.516265 · Cited by 86 · cited 2×
“Meta-analysis of studies using voxel-based morphometry of the segmented grey matter, revealed changes confined to the primary motor cortex in ALS (Chen and Ma, 2010).”
MethodIntrahemispheric and interhemispheric structural network abnormalities in PLS and ALS
Agosta, F., Galantucci, S., Riva, N., Chiò, A., Messina, S., Iannaccone, S., Calvo, A., Silani, V., Copetti, M., Falini, A., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22286 · Cited by 81 · cited 1×
“…are mainly located in the interhemispheric motor fibres of the body (Chapman et al., 2013), and seem exaggerated in patients with primary lateral sclerosis which are considered part of the spectrum of ALS in the wider use of the diagnostic term (Ciccarelli et al., 2009; Agosta et al., 2013).”
BackgroundAgosta, F., Gorno‐Tempini, M. L., Pagani, E., Sala, S., Caputo, D., Perini, M., Bartolomei, I., Fruguglietti, M. E., & Filippi, M. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802603841 · Cited by 79 · cited 2×
“In the small number of studies undertaken to date, signifi- cant white and grey matter changes over time have been observed in some (Agosta et al., 2009; Senda et al., 2011; van der Graaff et al., 2011; Keil et al., 2012; Verstraete et al., 2012), but not others (Blain et al., 2007; Mitsumoto et…”
BackgroundMenke, R., Abraham, I. E., Thiel, C., Filippini, N., Knight, S., Talbot, K., & Turner, M. R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1122 · Cited by 78 · cited 3×
“We observed some regional grey and white matter changes in relation to clinical features, and in exploratory region of interest analysis confirmed our previous observations of correlation of fractional anisotropy within the corticospinal tract in relation to rate of progression (Menke et al., 2012).”
ResultSelf-citationFekete, T., Zach, N., Mujica-Parodi, L. R., & Turner, M. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085190 · Cited by 69 · cited 1×
“…our study of apparently sporadic patients suggests that these grey matter changes may be common to all cases of ALS eventually, rather than being geno- type-specific, including those changes in the basal ganglia, also noted by others (Bede et al., 2013c; Fekete et al., 2013; Sharma et al., 2013).”
BackgroundSelf-citationMyelin imaging in amyotrophic and primary lateral sclerosis
Kolind, S., Sharma, R., Knight, S., Johansen-Berg, H., Talbot, K., & Turner, M. R. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.794843 · Cited by 69 · cited 2×
“A smaller proportion of these patients have appeared in previously published studies undertaken as the cohort was still being recruited (Filippini et al., 2010; Douaud et al., 2011; Menke et al., 2012; Kolind et al., 2013; Stagg et al., 2013).”
BackgroundResultSelf-citationAshburner, J., & Friston, K. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012372560-8/50005-x · Cited by 69
Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS
Stagg, C. J., Knight, S., Talbot, K., Jenkinson, M., Maudsley, A. A., & Turner, M. R. (2013) · Neurology · doi:10.1212/wnl.0b013e318281ccec · Cited by 68 · cited 1×
“A smaller proportion of these patients have appeared in previously published studies undertaken as the cohort was still being recruited (Filippini et al., 2010; Douaud et al., 2011; Menke et al., 2012; Kolind et al., 2013; Stagg et al., 2013).”
ResultSelf-citationNg, M., Ho, J. T., Ho, S., Lee, R., Li, G., Cheng, T., Song, Y., Ho, P. W., Fong, G. C., Mak, W., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21217 · Cited by 63 · cited 2×
“Asymptomatic carriers of pathogenic mutations in SOD1 were reported to have detectable fractional anisotropy decreases in the corticospinal tracts (Ng et al., 2008), and further DTI studies in similar patient groups are underway (Benatar and Wuu, 2012).”
BackgroundMRI predictors of long‐term evolution in amyotrophic lateral sclerosis
Agosta, F., Pagani, E., Petrolini, M., Sormani, M. P., Caputo, D., Perini, M., Prelle, A. C., Salvi, F., & Filippi, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07445.x · Cited by 62 · cited 2×
“Studies of baseline MRI measures in relation to overall survival (Agosta et al., 2010), or surface-based morphometry change in the temporal lobes (Verstraete et al., 2012), may offer further potential in this regard.”
BackgroundDiffusion tensor MRI of the corpus callosum in amyotrophic lateral sclerosis
Chapman, M. C., Jelsone-Swain, L. M., Johnson, T. D., Gruis, K. L., & Welsh, R. C. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24218 · Cited by 48 · cited 2×
“Corpus callosum changes are mainly located in the interhemispheric motor fibres of the body (Chapman et al., 2013), and seem exaggerated in patients with primary lateral sclerosis which are considered part of the spectrum of ALS in the wider use of the diagnostic term (Ciccarelli et al., 2009;…”
BackgroundTrojsi, F., Corbo, D., Caiazzo, G., Piccirillo, G., Monsurrò, M. R., Cirillo, S., Esposito, F., & Tedeschi, G. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.785569 · Cited by 40 · cited 1×
“Corpus callosum and superior longitudinal fascicle regions of interest were chosen based on previously published studies reporting involvement of extra-motor tracts in ALS (Filippini et al., 2010; Sarro et al., 2011; Trojsi et al., 2013).”
MethodDiffusion Tensor Imaging of Basal Ganglia and Thalamus in Amyotrophic Lateral Sclerosis
Sharma, K. R., Sheriff, S., Maudsley, A. A., & Govind, V. (2012) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2011.00679.x · Cited by 39 · cited 1×
“…our study of apparently sporadic patients suggests that these grey matter changes may be common to all cases of ALS eventually, rather than being geno- type-specific, including those changes in the basal ganglia, also noted by others (Bede et al., 2013c; Fekete et al., 2013; Sharma et al., 2013).”
Background
Cited by
A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis
Müller, H.-P., Turner, M. R., Grosskreutz, J., Abrahams, S., Bede, P., Govind, V., Prudlo, J., Ludolph, A. C., Filippi, M., & Kassubek, J. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311952 · Cited by 175
“sensitive cerebral pathology found in cross-sectional MRI studies in ALS patients has been in the white matter tracts,[14] in contrast to the characteristic hippocampal atrophy that largely defines Alzheimer’s Disease.”
BackgroundSelf-citationCerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
Thompson, A. G., Gray, E., Thézénas, M., Charles, P. D., Evetts, S., Hu, M. T., Talbot, K., Fischer, R., Kessler, B. M., & Turner, M. R. (2018) · Annals of Neurology · doi:10.1002/ana.25143 · Cited by 130
Self-citationLongitudinal imaging in C9ORF72 mutation carriers: relationship to phenotype
Floeter, M. K., Bageac, D., Danielian, L. E., Braun, L. E., Traynor, B. J., & Kwan, J. Y. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.10.014 · Cited by 75
“Our finding of ventricular enlargement in the symptomatic C9+ group over 6 months is consistent with previous longitudinal studies in sporadic ALS that detected grey matter loss over a 6-month (Menke et al., 2014) or 1-year (Kwan et al.”
11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
“In addition, voxelbased morphometry studies confirmed a widespread grey matter atrophy in sALS patients, peaking in the motor cortices and extending to the basal ganglia, thalamus, and cerebellum.(71,72) The brainstem involvement was also reported in a large population of sALS and primary lateral sclerosis patients, d…”
BackgroundOccasional essay: upper motor neuron syndrome in amyotrophic lateral sclerosis
Swash, M., Burke, D., Turner, M. R., Grosskreutz, J., Leigh, P. N., deCarvalho, M., & Kiernan, M. C. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321938 · Cited by 35
Self-citation
Metadata
- Authors
- Menke, R. A. L., Körner, S., Filippini, N., Douaud, G., Knight, S., Talbot, K., & Turner, M. R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-20
- Volume
- 137
- Issue
- 9
- Pages
- 2546-2555
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2082468728
- Cited by
- 189
- References
- 70
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.